Barrett's esophagus: progression to adenocarcinoma and markers

Ann N Y Acad Sci. 2011 Sep:1232:210-29. doi: 10.1111/j.1749-6632.2011.06053.x.

Abstract

The following on progression to adenocarcinoma and markers of Barrett's esophagus includes commentariess on the expression of claudin 4 in Barrett's adenocarcinoma; the role of acid and bile salts; the role of insulin-like growth factor; the value of reactive oxygen species; the importance of abnormal methylation; genetic alterations in stromal cells and genomic changes in the epithelial cells; the value of confocal laser endomicroscopy for the subsurface analysis of the mucosa; indications for statins as adjuvant chemotherapeutic agent; the sequence of molecular events in malignant progression in Barrett's mucosa; and the value of the macroscopic markers and of p53 mutations.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenocarcinoma / pathology*
  • Barrett Esophagus / pathology*
  • Biomarkers, Tumor*
  • Disease Progression
  • Esophageal Neoplasms / pathology*
  • Humans
  • NADPH Oxidases / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Biomarkers, Tumor
  • NADPH Oxidases